Valerio Gristina

Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score

Antonio Galvano, Marta Peri, Aurelia Guarini et al. · Therapeutic Advances in Medical Oncology · 2020 · 61 citations · Full text

Medicine, Immunology, Oncology +16

Tumor mutational burden on cytological samples: A pilot study

Francesco Pepe, Pasquale Pisapia, Valerio Gristina et al. · Cancer Cytopathology · 2020 · 47 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links

Valerio Gristina, MARIA GRAZIA CUPRI, Martina Torchio et al. · Biomedical Reports · 2014 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups

Francesco Passiglia, Antonio Galvano, Valerio Gristina et al. · Translational Lung Cancer Research · 2021 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study

Valerio Gristina, Nadia Barraco, Maria La Mantia et al. · Cancers · 2022 · 24 citations · Full text

Medicine, Molecular Medicine, Oncology +17